SMTL ID : 3e8n.2 (1 other biounit)

X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) complexed with a potent inhibitor RDEA119 and MgATP

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

homo-dimer

Ligands

2 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 4 residues within 4Å: Chain A: S.134, N.135, D.148 Ligands: ATP.2 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.148, H2O.1, H2O.1 MG.4: 4 residues within 4Å: Chain B: S.134, N.135, D.148 Ligands: ATP.5 3 PLIP interactions: 1 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:D.148, H2O.3, H2O.3

2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.2: 22 residues within 4Å: Chain A: L.14, A.16, G.17, N.18, G.20, V.22, A.35, K.37, M.83, E.84, H.85, M.86, S.90, D.92, Q.93, K.132, S.134, N.135, L.137, D.148 Ligands: MG.1, VRA.3 18 PLIP interactions: 18 interactions with chain A Hydrogen bonds: A:N.18, A:N.18, A:E.84, A:M.86, A:S.90, A:S.90, A:S.90, A:S.134, A:S.134 Water bridges: A:G.19, A:G.20, A:K.37, A:K.37, A:Q.93, A:N.135, A:D.148 Salt bridges: A:K.37, A:K.132 ATP.5: 22 residues within 4Å: Chain B: L.14, A.16, G.17, N.18, G.20, V.22, A.35, K.37, M.83, E.84, H.85, M.86, S.90, D.92, Q.93, K.132, S.134, N.135, L.137, D.148 Ligands: MG.4, VRA.6 18 PLIP interactions: 18 interactions with chain B Hydrogen bonds: B:N.18, B:N.18, B:E.84, B:M.86, B:S.90, B:S.90, B:S.90, B:S.134, B:S.134 Water bridges: B:G.19, B:G.20, B:K.37, B:K.37, B:Q.93, B:N.135, B:D.148 Salt bridges: B:K.37, B:K.132

2 x VRA: N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[(2S)-2,3-dihydroxypropyl]cyclopropanesulfonamide(Non-covalent)

VRA.3: 17 residues within 4Å: Chain A: G.19, K.37, I.39, L.55, V.67, I.81, M.83, D.130, D.148, F.149, G.150, V.151, S.152, L.155, I.156, M.159 Ligands: ATP.2 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.39, A:I.81, A:L.155 Hydrogen bonds: A:K.37, A:D.148, A:D.148, A:D.148 Water bridges: A:G.20, A:D.130, A:D.130 pi-Stacking: A:F.149 Halogen bonds: A:V.67 VRA.6: 17 residues within 4Å: Chain B: G.19, K.37, I.39, L.55, V.67, I.81, M.83, D.130, D.148, F.149, G.150, V.151, S.152, L.155, I.156, M.159 Ligands: ATP.5 12 PLIP interactions: 12 interactions with chain B Hydrophobic interactions: B:I.39, B:I.81, B:L.155 Hydrogen bonds: B:K.37, B:D.148, B:D.148, B:D.148 Water bridges: B:G.20, B:D.130, B:D.130 pi-Stacking: B:F.149 Halogen bonds: B:V.67

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Iverson, C. et al., RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer. Cancer Res. (2009)

Release Date

2009-09-01

Peptides

Dual specificity mitogen-activated protein kinase kinase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Dual specificity mitogen-activated protein kinase kinase 1

Related Entries With Identical Sequence